Tablet Two-Dimensional Identifier Integration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing tablets with identifying information, such as QR codes, are complex and prone to damage or manipulation, compromising medicament safety and authentication.

Innovation Solution

A solid dosage form with a two-dimensional identifier, such as a QR code, integrated into the base body using screen printing, ensuring unambiguous authentication and enhanced safety by eliminating the need for separate substrate production and reducing the risk of damage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If QR codes are printed onto tablets using inkjet printing or 3D printing, then tablet identification capability is improved, but the identifier can easily be damaged or manipulated and production complexity increases

Engineering Contradiction:
Improveidentifier durabilityVSAvoidproduction process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges the identifier directly into the tablet matrix by incorporating colorants or fluorescent substances during the tablet compression process. This integration ensures the identifier becomes an inherent part of the tablet structure, making it resistant to damage or manipulation while eliminating separate printing steps. The identifier and medicinal substance are combined in a single production process, resolving the contradiction between reliability and production complexity.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The identifier is prepared and integrated into the tablet during the initial compression process rather than being added afterward. By incorporating the identifying colorants or fluorescent substances into the powder mixture before compression, the identifier is established as a fundamental component of the tablet, ensuring its durability and eliminating subsequent printing operations.

Inventive Principle:
Principle #10Preliminary action

2Ease of manufacture

If tablets are punched locally to indicate information, then production process is simple, but information capacity is limited and authentication capability is insufficient

Engineering Contradiction:
Improveproduction simplicityVSAvoidinformation capacity
Core Design Contradiction:
Ease of manufactureVSLoss of information

Solution Approach 1:

The patent employs colorants with different absorption spectra or fluorescent substances incorporated into the tablet matrix to encode information. By varying the color, fluorescence intensity, or spectral characteristics at different locations or regions of the tablet, extensive information can be conveyed beyond what simple punching can achieve, while maintaining the simplicity of the compression-based production process.

Inventive Principle:
Principle #32Color changes

Data Source

PatentUS12115130B2Tablet having a two-dimensional identifier
Publication Date: 2024.10.15 LAXXON MEDICAL AG
  • US12115130B2 patent drawing
  • US12115130B2 patent drawing
  • US12115130B2 patent drawing

AI summary

A solid dosage form for active ingredient release can be a preparation for medical, dental or cosmetic purposes, and is preferably a tablet. The solid dosage form comprises a three-dimensional base body which comprises an active ingredient. The solid dosage form further comprises a portion having a structure forming a two-dimensional identifier, such as, for instance, a QR code.